INSIDERFilingvia Quantisnow
Pear Therapeutics Inc. logo

Pear Therapeutics (PEAR) executive Brenner sold 8,690 shares for $9,820 at $1.13

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Erin K. Brenner (executive at Pear Therapeutics Inc., PEAR) reported that they sold 8,690 shares for $9,820 at $1.13 on Jan 20, 2023. After these transactions the filing shows 43,310 shares held directly.

Reporting person
Brenner Erin K.
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jan 20, 2023Open-market sale (S)Class A Common Stock1, 2-8,690$1.13$9,82043,310 direct

Holdings before and after

  • Class A Common Stock: 52,000 to 43,310 direct

Footnotes from the filing

  1. 1. The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary transaction by the Reporting Person.
  2. 2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $1.03 to $1.335, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.

Transaction codes in this filing

Open-market sale:
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.

FAQ

What did Brenner report in this PEAR Form 4?

Erin K. Brenner (executive at Pear Therapeutics Inc., PEAR) reported that they sold 8,690 shares for $9,820 at $1.13 on Jan 20, 2023. After these transactions the filing shows 43,310 shares held directly.

How many PEAR shares does Brenner hold after this filing?

The filing shows 43,310 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

Was this PEAR insider sale made under a 10b5-1 plan?

The filing's footnotes do not mention a Rule 10b5-1 trading plan.

What does transaction code S mean on an SEC Form 4?

Code S marks a sale in the open market or a private deal. The insider received cash for these securities.

Historical context for PEAR

Earlier insider filings at PEAR

Quantisnow market dataNASDAQ
Pear Therapeutics Inc. logo
PEAR
Pear Therapeutics Inc.
Market cap
30-day
Sector
Technology
Industry
Computer Software: Prepackaged Software
Listed since
2021
Get push alerts for PEAR

Follow PEAR and get a push notification the moment its next story breaks.

Full PEAR profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PEAR (Pear Therapeutics Inc.) and more on Quantisnow.